Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disease in which changes in stem cells within the bone marrow prompt red blood cells to break apart. This deprives the body of the normal flow ...

BOSTON, April 5, 2011 (GLOBE NEWSWIRE) -- Oncology Care Live (www.OncologyCarelive.com ), the live online oncology congress, today announced that Michael J. Borowitz ...

To help manage the symptoms — from fatigue and headache to bruising and bleeding — of this rare blood disease, follow these steps. “With good care and the right medicines, your PNH can be managed,” ...

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disease in which the immune system breaks apart the red blood cells (RBCs) in the body. The medical term for this premature rupture of RBCs is ...

—A literature review of AA and PNH symptoms indicates that patients and medical specialists differ significantly in how they rank symptoms. While the therapeutic landscape for hematologic diseases has ...

The FDA approved iptacopan (Fabhalta) as the first oral monotherapy for adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare but potentially fatal disorder affecting red blood cells (RBCs), ...

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disease that can cause fatigue due to anemia. PNH is closely associated with fatigue due to a loss of red blood cells, leading to anemia. This ...

A acquired deficiency in the PIGA gene alters red blood cells. Paroxysmal nocturnal hemoglobinuria results when these altered cells replicate. Medications can stop the breakdown of red blood cells and ...

Paroxysmal nocturnal hemoglobinuria (PNH) could be effectively treated by using eculizumab, which was found to be safe in patients. Eculizumab demonstrated long-term safety and efficacy when used to ...

Post hoc analyses of the phase 3 PEGASUS trial found that clinical and hematological improvements were associated with better patient-reported fatigue and physical function outcomes in paroxysmal ...